Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Julie So-Young Kim
CEOJulie So-Young Kim
Employees
47,029
Employees47,029
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,029
Employees47,029

TAK Key Statistics

Market cap
60.12B
Market cap60.12B
Price-Earnings ratio
-56.54
Price-Earnings ratio-56.54
Dividend yield
3.12%
Dividend yield3.12%
Average volume
1.91M
Average volume1.91M
High today
$18.56
High today$18.56
Low today
$18.35
Low today$18.35
Open price
$18.49
Open price$18.49
Volume
1.50M
Volume1.50M
52 Week high
$18.90
52 Week high$18.90
52 Week low
$12.99
52 Week low$12.99

TAK News

TipRanks 9h
Takeda Backs Real‑World Fruquintinib Study in Metastatic Colorectal Cancer

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. The study Fruquintinib in Patients With Metastatic Colorectal Cancer i...

TipRanks 1d
Takeda’s Replagal Trial in India: Fresh Clinical Update With Rare Disease Upside

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda’s latest clinical update centers on Fabry disease, a rare inher...

TipRanks 4d
Bayer, Takeda expected to announce new pricing deals with White House, FT says

U.S. President Donald Trump is expected to announce a new slate of drug-pricing deals on Monday following a planned meeting with representatives from a number o...

Analyst ratings

59%

of 17 ratings
Buy
58.8%
Hold
41.2%
Sell
0%

More TAK News

Benzinga 4d
Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug

On Friday, the U.S. Food and Drug Administration (FDA) approved Takeda Pharmaceutical Co. Ltd.‘s (NYSE:TAK) MIMRYLO (rusfertide) for polycythemia vera, a type o...

Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug
TipRanks 5d
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously delivered fi...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.